Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
412.40M | 429.63M | 408.55M | 333.95M | 265.99M | 274.72M | Gross Profit |
190.40M | 278.72M | 140.37M | 101.66M | 76.44M | 171.59M | EBIT |
33.01M | 46.28M | 49.13M | 31.81M | 20.56M | 16.82M | EBITDA |
61.51M | 87.80M | 87.01M | 66.13M | 50.77M | 43.92M | Net Income Common Stockholders |
19.94M | 31.31M | 31.26M | 18.73M | 9.97M | 9.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
29.35M | 65.60M | 76.00M | 84.29M | 73.32M | 31.09M | Total Assets |
170.10M | 450.97M | 420.86M | 403.40M | 356.29M | 287.26M | Total Debt |
19.57M | 205.26M | 166.38M | 173.20M | 180.77M | 129.42M | Net Debt |
-9.78M | 139.67M | 90.38M | 88.91M | 107.45M | 98.33M | Total Liabilities |
108.37M | 346.17M | 326.13M | 320.02M | 289.65M | 228.12M | Stockholders Equity |
60.92M | 102.85M | 92.97M | 81.77M | 64.78M | 57.05M |
Cash Flow | Free Cash Flow | ||||
33.52M | 27.63M | 53.03M | 70.18M | 51.91M | 42.63M | Operating Cash Flow |
47.64M | 51.13M | 63.04M | 80.69M | 57.88M | 51.26M | Investing Cash Flow |
-19.14M | -27.46M | -20.83M | -10.36M | -19.94M | -7.98M | Financing Cash Flow |
-38.52M | -34.16M | -51.23M | -60.49M | 4.88M | -26.27M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | €411.31M | 26.35 | 15.82% | 5.60% | -3.64% | -50.51% | |
62 Neutral | $6.88B | 11.32 | 2.90% | 3.87% | 2.70% | -24.57% | |
$276.87B | 55.94 | 28.67% | 1.06% | ― | ― | ||
€21.86B | 16.98 | 2.57% | 1.79% | ― | ― | ||
€21.26B | 18.77 | 7.52% | 3.46% | ― | ― | ||
€2.53B | 9.39 | 9.58% | 3.49% | ― | ― |
Roche Bobois SA reported its 2024 annual results, showing resilience despite a challenging market environment. The company saw a slight revenue decline of 3.6% to 414 million euros, with EBITDA aligning with expectations at 74.4 million euros. The company maintained strong financial health with significant cash flows and plans to propose a dividend of 1.25 euros per share. Strategic investments in expanding owned stores in key regions like the US and China are expected to support future growth, with a positive outlook for 2025 revenue and EBITDA.
Roche Bobois SA announced a share buyback program, authorized by the general meeting in June 2024, with transactions executed between February 10 and 14, 2025. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting its strong financial position and commitment to maintaining its market presence.
Roche Bobois has been selected to furnish the prestigious Peninsula Paris hotel’s terrace, featuring their iconic Bubble sofa and Aqua table, enhancing the hotel’s luxurious ambiance with a unique view of the Eiffel Tower. Additionally, Roche Bobois is involved in several high-profile projects, including furnishing the VIP lounge at the Bonhams Cars event in Paris and contributing to the renovation of the Keebler J. Straz lounge at the Metropolitan Opera House in New York, reinforcing its commitment to art, heritage, and innovation.
Roche Bobois announced its monthly information regarding voting rights, highlighting a total of 10,134,323 shares with 17,799,619 theoretical voting rights as of February 28, 2025. This announcement reflects the company’s commitment to transparency in its shareholder communications, which is crucial for maintaining investor trust and supporting its strategic positioning in the competitive furniture market.